BIO-key International, Inc. reported a 30% increase in Q3 revenue to $1.8 million compared to $1.4 million in Q3 2022. The company's gross profit also improved by 40% to $1.4 million, and the net loss per share was reduced by approximately 72% to ($0.08).
Revenue rose over 30% to $1.8M vs. $1.4M in Q3’22.
Gross profit improved more than 40% to $1.4M vs. $1.0M in Q3’22.
Q3’23 operating loss improved to approximately ($750,000) vs. an operating loss of ($2.4M) in Q3’22.
Q3’23 net loss per share reduced approximately 72% to ($0.08) vs. ($0.29) in Q3’22.
BIO-key anticipates top-line and bottom-line improvements, driven by the value proposition of its authentication solutions and the increasing need for multi-factor authentication due to cyber-insurer scrutiny and SEC regulations. Q4 is historically a strong quarter, and the company is confident about continued growth and improved bottom-line performance in 2024.